japan.

= in our Global Regulatory A–Z series.

( )
The PMDA, under Japan’s Ministry of Health, Labour and Welfare (MHLW), oversees the approval, safety monitoring, and regulation of pharmaceuticals, medical devices, and biologics in Japan.

💡 Did you know?
Japan emphasizes a rigorous pre-market review and post-marketing surveillance system. Products approved in other regions like the US or EU may still require local clinical data or bridging studies to meet PMDA standards.

At DDReg, we guide companies through Japan’s regulatory framework helping products reach the Japanese market efficiently and confidently.